This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2016 Jul;44(2):198-9.

doi: 10.1111/apt.13650.

Editorial: management of eosinophilic oesophagitis - efficacy vs. effectiveness

R D Frazier¹, R Fass²

Affiliations

Affiliations

¹ Division of Gastroenterology and Hepatology, The Esophageal and Swallowing Center, MetroHealth Medical Center, Case Western Reserve University, Cleveland, OH, USA.
² Division of Gastroenterology and Hepatology, The Esophageal and Swallowing Center, MetroHealth Medical Center, Case Western Reserve University, Cleveland, OH, USA. ronnie.fass@gmail.com.

PMID: 27296680
DOI: 10.1111/apt.13650

Editorial

Editorial: management of eosinophilic oesophagitis - efficacy vs. effectiveness

R D Frazier et al. Aliment Pharmacol Ther. 2016 Jul.

. 2016 Jul;44(2):198-9.

doi: 10.1111/apt.13650.

Authors

R D Frazier¹, R Fass²

Affiliations

¹ Division of Gastroenterology and Hepatology, The Esophageal and Swallowing Center, MetroHealth Medical Center, Case Western Reserve University, Cleveland, OH, USA.
² Division of Gastroenterology and Hepatology, The Esophageal and Swallowing Center, MetroHealth Medical Center, Case Western Reserve University, Cleveland, OH, USA. ronnie.fass@gmail.com.

PMID: 27296680
DOI: 10.1111/apt.13650

No abstract available

PubMed Disclaimer

Comment in

Editorial: management of eosinophilic oesophagitis - efficacy vs. effectiveness. Authors' reply.
Philpott H, Gibson PR. Philpott H, et al. Aliment Pharmacol Ther. 2016 Jul;44(2):199-200. doi: 10.1111/apt.13666. Aliment Pharmacol Ther. 2016. PMID: 27296681 No abstract available.

Comment on

A prospective open clinical trial of a proton pump inhibitor, elimination diet and/or budesonide for eosinophilic oesophagitis.
Philpott H, Nandurkar S, Royce SG, Thien F, Gibson PR. Philpott H, et al. Aliment Pharmacol Ther. 2016 May;43(9):985-93. doi: 10.1111/apt.13576. Epub 2016 Mar 4. Aliment Pharmacol Ther. 2016. PMID: 26939578 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions

LinkOut - more resources

Medical
- MedlinePlus Health Information